Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer.
作者： Matthias M. Heck , Robert Tauber , Sebastian Schwaiger , Margitta Retz , Calogero D’Alessandria
DOI: 10.1016/J.EURURO.2018.11.016
关键词: Oncology 、 Enzalutamide 、 Medicine 、 Taxane 、 Internal medicine 、 Anemia 、 Chemotherapy 、 Prostate cancer 、 Neutropenia 、 Toxicity 、 Lactate dehydrogenase
摘要: … In conclusion, RLT with 177 Lu-PSMA-I&T showed mild toxicity and good antitumor activity in a subgroup of late-stage mCRPC patients. A PSA decline of ≥50% under RLT within 12 …
sci-hub.se 参考文章(14)
Andreas Delker, Wolfgang Peter Fendler, Clemens Kratochwil, Anika Brunegraf, Astrid Gosewisch, Franz Josef Gildehaus, Stefan Tritschler, Christian Georg Stief, Klaus Kopka, Uwe Haberkorn, Peter Bartenstein, Guido Böning, Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 43, pp. 42- 51 ,(2016) , 10.1007/S00259-015-3174-7
K. Herrmann, C. Bluemel, M. Weineisen, M. Schottelius, H.-J. Wester, J. Czernin, U. Eberlein, S. Beykan, C. Lapa, H. Riedmiller, M. Krebs, S. Kropf, A. Schirbel, A. K. Buck, M. Lassmann, Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy The Journal of Nuclear Medicine. ,vol. 56, pp. 855- 861 ,(2015) , 10.2967/JNUMED.115.156133
Christian M. Zechmann, Ali Afshar-Oromieh, Tom Armor, James B. Stubbs, Walter Mier, Boris Hadaschik, John Joyal, Klaus Kopka, Jürgen Debus, John W. Babich, Uwe Haberkorn, Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 41, pp. 1280- 1292 ,(2014) , 10.1007/S00259-014-2713-Y
R. P. Baum, H. R. Kulkarni, C. Schuchardt, A. Singh, M. Wirtz, S. Wiessalla, M. Schottelius, D. Mueller, I. Klette, H.-J. Wester, 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy The Journal of Nuclear Medicine. ,vol. 57, pp. 1006- 1013 ,(2016) , 10.2967/JNUMED.115.168443
Tobias Maurer, Jürgen E. Gschwend, Isabel Rauscher, Michael Souvatzoglou, Bernhard Haller, Gregor Weirich, Hans-Jürgen Wester, Matthias Heck, Hubert Kübler, Ambros J. Beer, Markus Schwaiger, Matthias Eiber, Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer The Journal of Urology. ,vol. 195, pp. 1436- 1443 ,(2016) , 10.1016/J.JURO.2015.12.025
Matthias M. Heck, Margitta Retz, Calogero D'Alessandria, Isabel Rauscher, Klemens Scheidhauer, Tobias Maurer, Enno Storz, Friederike Janssen, Margret Schottelius, Hans-Jürgen Wester, Jürgen E. Gschwend, Markus Schwaiger, Robert Tauber, Matthias Eiber, Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer. The Journal of Urology. ,vol. 196, pp. 382- 391 ,(2016) , 10.1016/J.JURO.2016.02.2969
Thomas Pyka, Shozo Okamoto, Marielena Dahlbender, Robert Tauber, Margitta Retz, Matthias Heck, Nagara Tamaki, Markus Schwaiger, Tobias Maurer, Matthias Eiber, Comparison of bone scintigraphy and 68 Ga-PSMA PET for skeletal staging in prostate cancer European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 43, pp. 2114- 2121 ,(2016) , 10.1007/S00259-016-3435-0
C. Kratochwil, F. Bruchertseifer, F. L. Giesel, M. Weis, F. A. Verburg, F. Mottaghy, K. Kopka, C. Apostolidis, U. Haberkorn, A. Morgenstern, 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer. The Journal of Nuclear Medicine. ,vol. 57, pp. 1941- 1944 ,(2016) , 10.2967/JNUMED.116.178673
Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil, Uwe Haberkorn, Michael Schäfers, Markus Essler, Richard P. Baum, Harshad R. Kulkarni, Matthias Schmidt, Alexander Drzezga, Peter Bartenstein, Andreas Pfestroff, Markus Luster, Ulf Lützen, Marlies Marx, Vikas Prasad, Winfried Brenner, Alexander Heinzel, Felix M. Mottaghy, Juri Ruf, Philipp Tobias Meyer, Martin Heuschkel, Maria Eveslage, Martin Bögemann, Wolfgang Peter Fendler, Bernd Joachim Krause, German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients. The Journal of Nuclear Medicine. ,vol. 58, pp. 85- 90 ,(2017) , 10.2967/JNUMED.116.183194
Matthias Eiber, Isabel Rauscher, Tobias Maurer, Matthias Heck, Robert Tauber, Hans Wester, Margitta Retz, Calogero D`Alessandria, Markus Schwaiger, Systemic radioligand therapy with 177Lu-PSMA I&T in patients with metastatic castration-resistant prostate cancer The Journal of Nuclear Medicine. ,vol. 57, pp. 61- 61 ,(2016)